ABILIFY sol inj 7.5 mg/ml flac 1.3 ml
7680578130014
CH-57813
N05AX12
01.05.0.
1 / 3
google
Details
- Product number
- 5781301
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- aripiprazolum 7.5 mg, acidum tartaricum, sulfobutylbetadexum natricum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 4.79 mg.
Articles (1)
Abilify 7,5 mg / ml, Injektionslösung i.m.
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
7.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
4.79 MG | Substance | HBESI |
Authorization holder
Otsuka Pharmaceutical
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 57813
- Drug name
- Abilify, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- N05AX12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 06/02/2008
- Authorization expiration date
- 31/12/9999
- IT number
- 01.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ABILIFY sol inj 7.5 mg/ml flac 1.3 ml
- Description (DE)
- ABILIFY Inj Lös 7.5 mg/ml Durchstf 1.3 ml
- Market launch
- 06/02/2008
- Narcotic (BTM)
- No